Pancreatic Cancer Research

ResearcherTongji HospitalNo recent work listed

Yan Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9475-1275; OpenAlex author ID A5009828453. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper · 2018: 4 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 10

  1. Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition. Co-author DOI 10.1016/j.ebiom.2022.104352↗
  2. Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Co-author DOI 10.1186/s12943-020-01249-8↗
  3. TFEB-driven autophagy potentiates TGF-β induced migration in pancreatic cancer cells. Co-author DOI 10.1186/s13046-019-1343-4↗
  4. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB. Co-author DOI 10.1016/j.taap.2018.08.003↗
  5. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data. Co-author DOI 10.1038/s41598-018-22493-5↗
  6. Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway. Co-author DOI 10.18632/oncotarget.22976↗
  7. Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma. First author DOI 10.18632/oncotarget.24443↗
  8. Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin. First author DOI 10.3390/ijms18020370↗
  9. Par3 regulates invasion of pancreatic cancer cells via interaction with Tiam1. Co-author DOI 10.1007/s10238-015-0365-2↗
  10. Blocking NF-κB Is Essential for the Immunotherapeutic Effect of Recombinant IL18 in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-15-1144↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xingjun Guo · 9 shared papers, 2016–2022 · strength 0.67
  2. Ruizhi He · 9 shared papers, 2016–2022 · strength 0.67
  3. Renyi Qin · 9 shared papers, 2016–2022 · strength 0.65
  4. Min Wang · 8 shared papers, 2016–2022 · strength 0.60
  5. Shutao Pan · 6 shared papers, 2018–2022 · strength 0.50
  6. Xiuhui Shi · 6 shared papers, 2018–2022 · strength 0.50
  7. Chunle Zhao · 4 shared papers, 2018–2022 · strength 0.35
  8. Xu Li · 4 shared papers, 2016–2022 · strength 0.31
  9. Min Zhou · 4 shared papers, 2018–2019 · strength 0.31
  10. Chengjian Shi · 4 shared papers, 2016–2020 · strength 0.23
  11. Yuhui Liu · 2 shared papers, 2019–2022 · strength 0.20
  12. Min Zhou · 2 shared papers, 2018–2022 · strength 0.19
  13. Jianxin Jiang · 3 shared papers, 2016–2020 · strength 0.17
  14. Li Xu · 2 shared papers, 2019–2020 · strength 0.16
  15. Shuo Yu · 2 shared papers, 2018–2020 · strength 0.16
  16. Xiaodong Xu · 2 shared papers, 2016–2020 · strength 0.13
  17. Yuqing Zhang · 1 shared paper, 2022 · strength 0.12
  18. Min Li · 1 shared paper, 2022 · strength 0.12
  19. Taoyuan Yin · 1 shared paper, 2022 · strength 0.12
  20. Zhijun Zhou · 1 shared paper, 2022 · strength 0.12
  21. Jingxuan Yang · 1 shared paper, 2022 · strength 0.12
  22. Mingyang Liu · 1 shared paper, 2022 · strength 0.12
  23. Jun Gong · 1 shared paper, 2020 · strength 0.08
  24. Min Li · 1 shared paper, 2020 · strength 0.08
  25. Renyi Qin · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.